EUVIMEDEUVIMED entdecken
Crossref

Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats

Leila Safaeian iD, Maryam Farsiabi, Zahra Haghighatian, Mansooreh Asghari-Varzaneh

Drug Research · 01.07.2026 · 76 (04/06) · 131-138

DOI: 10.1055/a-2829-7178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2026. Verfasst von Leila Safaeian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan Universit…. Hauptthemen laut MEDLINE: Doxorubicin, Hydroxybenzoates, Cardiotoxicity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxorubicin, an anti-neoplastic agent, is linked with a risk of cardiotoxicity following acute or cumulative doses. Protocatechuic acid ethyl ester, as a natural phenolic acid derivative, inhibits a prolyl hydroxylase enzyme with iron-chelating and antioxidative properties. This study evaluated the effects of protocatechuic acid ethyl ester on cardiotoxicity induced by doxorubicin in an animal model.

Methods

Male Wistar rats were pretreated orally with 50, 75, and 150 mg/kg of protocatechuic acid ethyl ester for 14 days. Cardiotoxicity was induced by the acute injection of doxorubicin (20 mg/kg) on the 10th day. Recording of the electrocardiogram, assessment of serum parameters of aspartate aminotransferase, lactate dehydrogenase, creatine phosphokinase-MB, malondialdehyde and total antioxidant capacity as ferric reducing antioxidant power, and histopathological inspection of heart tissues were performed.

Results

Protocatechuic acid ethyl ester at all doses prevented the increase in heart rate and the decrease in the R-R interval induced by doxorubicin. Higher doses of protocatechuic acid ethyl ester (75 and 150 mg/kg) were able to improve most of the serum and tissue parameters of cardiac injury. Protocatechuic acid ethyl ester at a dose of 150 mg/kg significantly reduced lactate dehydrogenase (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinHydroxybenzoatesCardiotoxicityAnimalsMaleRats, WistarRatsAntioxidantsMalondialdehydeElectrocardiographyOxidative StressAspartate AminotransferasesL-Lactate DehydrogenaseMyocardiumHeart RateHeartAntibiotics, AntineoplasticDisease Models, Animal

Substanzen

DoxorubicinHydroxybenzoatesAntioxidantsprotocatechuic acidMalondialdehydeAspartate AminotransferasesL-Lactate DehydrogenaseAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of).
  • Department of Pathology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran (the Islamic Republic of).
  • Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of).

ORCID-Profile: Leila Safaeian

Zitieren

APA

Safaeian, L., Farsiabi, M., Haghighatian, Z., & Asghari-Varzaneh, M. (2026). Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats. Drug Research, 76(04/06), 131-138. https://doi.org/10.1055/a-2829-7178

Vancouver

Safaeian L, Farsiabi M, Haghighatian Z, Asghari-Varzaneh M. Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats. Drug Research. 2026;76(04/06):131-138. doi:10.1055/a-2829-7178

BibTeX
@article{Safaeian2026,
  author = {Safaeian, Leila and Farsiabi, Maryam and Haghighatian, Zahra and Asghari-Varzaneh, Mansooreh},
  title = {Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats},
  journal = {Drug Research},
  year = {2026},
  volume = {76},
  number = {04/06},
  pages = {131--138},
  doi = {10.1055/a-2829-7178}
}
Kostenlos starten →